Dr. Philip Walther

Biography

Philip John Walther is a Professor in the Department of Urology at Duke University. His research primarily focuses on developmental therapeutics for systemic urologic cancers, particularly bladder and prostate cancers, emphasizing drug synergy and preclinical screening of effective new agents. He has significant expertise in p53 mutations in prostate cancer, studying their role in the multistep process of carcinogenesis, and has explored the association of oncogenic types of human papillomavirus with urologic malignancy. Walther serves as the Principal Investigator for multi-institutional trials evaluating the efficacy of biological response modifiers like gamma-interferon in renal cancer treatment. His academic background includes extensive residency training in urologic surgery, surgery, and an MBA, MD, and PhD from Duke University. He holds numerous grants focusing on prostate cancer research and has held positions such as Assistant Professor and Associate Professor in Pathology and Urology.

Research Interests

Experience